We are live on ! Find out more
LVAC

LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC

Delisted

LVAC was delisted on the 10th of May, 2023.

Back to rankings

53 hedge funds and large institutions have $104M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

10% more capital invested

Capital invested by funds: $94.6M → $104M (+$9.21M)

8% more funds holding

Funds holding: 49 → 53 (+4)

71% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 7

Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
7
Closed
7
Calls
$206K
Puts
–
Net Calls
+$206K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
CCA
Castle Creek Arbitrage
Colorado
+$6.07M
2
PC
Periscope Capital
Ontario, Canada
+$2.61M
3
CCM
Context Capital Management
California
+$2.28M
4
BI
Bulldog Investors
New Jersey
+$542K
5
EC
Elequin Capital
New York
+$506K

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$2.88M
2
JP Morgan Chase
JP Morgan Chase
New York
-$2.77M
3
BCM
Basso Capital Management
Connecticut
-$1.45M
4
CM
Cohanzick Management
New York
-$517K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$230K
Name Holding Trade Value Shares
Change 		Change in
Stake
AMC
26
Atlas Merchant Capital
New York
$1.26M +$1.24M +122,400 New
SSA
27
Schonfeld Strategic Advisors
New York
$1.23M +$473K +46,768 +64%
MTCM
28
Mint Tower Capital Management
Netherlands
$1.02M – – –
Walleye Capital
29
Walleye Capital
New York
$670K – – –
SAMU
30
SONA Asset Management (US)
New York
$611K – – –
Walleye Trading
31
Walleye Trading
New York
$550K – – –
BI
32
Bulldog Investors
New Jersey
$547K +$542K +53,500 New
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$518K -$230K -22,740 -31%
WAM
34
Weiss Asset Management
Massachusetts
$514K – – –
WA
35
Whitebox Advisors
Minnesota
$510K – – –
EC
36
Elequin Capital
New York
$510K +$506K +50,000 New
HF
37
HRT Financial
New York
$503K – – –
SV
38
Starboard Value
New York
$427K – – –
PP
39
Paloma Partners
Connecticut
$411K – – –
DFCM
40
Dark Forest Capital Management
Puerto Rico
$377K +$375K +37,027 New
Verition Fund Management
41
Verition Fund Management
Connecticut
$361K – – –
Calamos Advisors
42
Calamos Advisors
Illinois
$257K – – –
LP
43
LMR Partners
United Kingdom
$255K +$253K +25,000 New
GCL
44
Glazer Capital LLC
New York
$242K -$26.3K -2,595 -10%
AllianceBernstein
45
AllianceBernstein
Tennessee
$183K -$68.6K -6,775 -27%
FTCM
46
First Trust Capital Management
Illinois
$160K – – –
VF
47
Virtu Financial
New York
$146K +$144K +14,236 New
CAPTRUST Financial Advisors
48
CAPTRUST Financial Advisors
North Carolina
$108K +$107K +10,581 New
DCM
49
Dupont Capital Management
Delaware
$103K – – –
ETH
50
Exos TFP Holdings
New York
$58.3K +$58K +5,726 New
1
2
3

LVAC Hedge Fund Activity: Q4 2022 in Review

53 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q4 2022, worth a combined $104M — up 9.7% from $94.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new LVAC positions and 7 closed out — a net gain of 4 holders — while 2 added to existing stakes and 7 trimmed.

The largest buyer was Castle Creek Arbitrage, opening a new position worth an estimated $6.07M. The largest seller was UBS O'Connor, exiting entirely with an estimated $2.88M sold.

  • 53 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q4 2022, up from 49 in Q3 2022.
  • Funds reported $104M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q4 2022, up 9.7% quarter-over-quarter.
  • 11 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q4 2022 and 7 closed out, a net change of +4 holders.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q4 2022 was Castle Creek Arbitrage, an estimated $6.07M added.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q4 2022 was UBS O'Connor, an estimated $2.88M sold.

Based on aggregated 13F filings for Q4 2022.